Zimmer Biomet Holdings Inc (ZBH)

113.16
-0.10(-0.09%)
After Hours
109.47
-3.69(-3.26%)
- Real-time Data
  • Volume:
    534,218
  • Day's Range:
    113.00 - 114.37
  • 52 wk Range:
    100.39 - 149.17

ZBH Overview

Prev. Close
113.26
Day's Range
113-114.37
Revenue
7.92B
Open
113.83
52 wk Range
100.39-149.17
EPS
1.1
Volume
534,218
Market Cap
23.72B
Dividend (Yield)
0.96
(0.85%)
Average Vol. (3m)
1,215,868
P/E Ratio
82.09
Beta
1.15
1-Year Change
-21.71%
Shares Outstanding
209,577,347
Next Earnings Date
Nov 03, 2022
What is your sentiment on Zimmer Biomet?
or
Market is currently closed. Voting is open during market hours.

Zimmer Biomet Holdings Inc News

Welcome to Your News Upgrade

Be the First to Know and Act on Market Moving News.

Welcome to Your News Upgrade

Zimmer Biomet Holdings Inc Analysis

Zimmer Biomet Holdings Inc Company Profile

Zimmer Biomet Holdings Inc Company Profile

Zimmer Biomet Holdings, Inc. is a musculoskeletal healthcare company. The Company is engaged in the design, manufacture and marketing of orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; spine, craniomaxillofacial and thoracic (CMFT) products; dental implants, and related surgical products. The Company's products and solutions help treat patients suffering from disorders of, or injuries to, bones, joints or supporting soft tissues. It operates through four segments: Americas Orthopedics, Europe, Middle East and Africa (EMEA), Asia Pacific, and Americas Spine and Global Dental. Its knee brands include Persona Knee, NexGen Knee Implants, Vanguard Knee and Oxford Partial Knee. Its hip brands include Taperloc Hip System, Avenir Complete Hip System, Arcos Modular Hip System and G7 Acetabular System. Its S.E.T. brands include JuggerKnot Soft Anchor System, Gel-One1 Cross-linked Hyaluronate, Comprehensive Shoulder and others.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellStrong SellNeutralBuyStrong Sell
Technical IndicatorsStrong SellStrong SellStrong SellStrong BuyStrong Sell
SummaryStrong SellStrong SellSellStrong BuyStrong Sell
  • Was already priced in. Profit taking. Buy at $140
    0
    • "Zimmer Biomet reported on Tuesday second quarter earnings that beat analysts' forecasts and revenue that topped expectations." So, why the sell off?
      1
      • Great opportunity at 80$
        0